v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Revenue $ 39,145 $ 21,426 $ 101,713 $ 47,777
Cost of revenue 28,630 18,108 76,178 45,480
Gross profit (loss) 10,515 3,318 25,535 2,297
Operating expenses:        
Research and development 6,407 2,509 14,305 6,674
Selling, general and administrative 8,834 5,501 26,941 16,799
Total operating expenses 15,241 8,010 41,246 23,473
Loss from operations (4,726) (4,692) (15,711) (21,176)
Other income, net 1,227 800 4,012 1,543
Net loss (3,499) (3,892) (11,699) (19,633)
Increase in net loss due to warrant modification 0 0 (1,921) 0
Net loss attributable to common stockholders (3,499) (3,892) (13,620) (19,633)
Net loss attributable to common stockholders $ (3,499) $ (3,892) $ (13,620) $ (19,633)
Weighted-average common shares outstanding:        
Weighted-average common shares outstanding, basic (in shares) 146,332,565 126,630,085 142,283,973 122,137,964
Weighted-average common shares outstanding, diluted (in shares) 146,332,565 126,630,085 142,283,973 122,137,964
Net loss per share of common stock:        
Net loss per share of common stock, basic (in dollars per share) $ (0.02) $ (0.03) $ (0.10) $ (0.16)
Net loss per share of common stock, diluted (in dollars per share) $ (0.02) $ (0.03) $ (0.10) $ (0.16)

Source